List of Tables
Table 1. Global Blocking Peptides Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Blocking Peptides Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Blocking Peptides Market Competitive Situation by Manufacturers in 2024
Table 4. Global Blocking Peptides Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Blocking Peptides Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Blocking Peptides Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Blocking Peptides Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Blocking Peptides Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Blocking Peptides, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Blocking Peptides, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Blocking Peptides, Product Type & Application
Table 12. Global Key Manufacturers of Blocking Peptides, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Blocking Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blocking Peptides as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Blocking Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Blocking Peptides Sales by Region (2020-2025) & (K Units)
Table 18. Global Blocking Peptides Sales Market Share by Region (2020-2025)
Table 19. Global Blocking Peptides Sales by Region (2026-2031) & (K Units)
Table 20. Global Blocking Peptides Sales Market Share by Region (2026-2031)
Table 21. Global Blocking Peptides Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Blocking Peptides Revenue Market Share by Region (2020-2025)
Table 23. Global Blocking Peptides Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Blocking Peptides Revenue Market Share by Region (2026-2031)
Table 25. North America Blocking Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Blocking Peptides Sales by Country (2020-2025) & (K Units)
Table 27. North America Blocking Peptides Sales by Country (2026-2031) & (K Units)
Table 28. North America Blocking Peptides Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Blocking Peptides Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Blocking Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Blocking Peptides Sales by Country (2020-2025) & (K Units)
Table 32. Europe Blocking Peptides Sales by Country (2026-2031) & (K Units)
Table 33. Europe Blocking Peptides Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Blocking Peptides Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Blocking Peptides Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Blocking Peptides Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Blocking Peptides Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Blocking Peptides Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Blocking Peptides Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Blocking Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Blocking Peptides Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Blocking Peptides Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Blocking Peptides Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Blocking Peptides Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Blocking Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Blocking Peptides Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Blocking Peptides Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Blocking Peptides Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Blocking Peptides Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Blocking Peptides Sales (K Units) by Type (2020-2025)
Table 51. Global Blocking Peptides Sales (K Units) by Type (2026-2031)
Table 52. Global Blocking Peptides Sales Market Share by Type (2020-2025)
Table 53. Global Blocking Peptides Sales Market Share by Type (2026-2031)
Table 54. Global Blocking Peptides Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Blocking Peptides Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Blocking Peptides Revenue Market Share by Type (2020-2025)
Table 57. Global Blocking Peptides Revenue Market Share by Type (2026-2031)
Table 58. Global Blocking Peptides Price (US$/Unit) by Type (2020-2025)
Table 59. Global Blocking Peptides Price (US$/Unit) by Type (2026-2031)
Table 60. Global Blocking Peptides Sales (K Units) by Application (2020-2025)
Table 61. Global Blocking Peptides Sales (K Units) by Application (2026-2031)
Table 62. Global Blocking Peptides Sales Market Share by Application (2020-2025)
Table 63. Global Blocking Peptides Sales Market Share by Application (2026-2031)
Table 64. Global Blocking Peptides Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Blocking Peptides Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Blocking Peptides Revenue Market Share by Application (2020-2025)
Table 67. Global Blocking Peptides Revenue Market Share by Application (2026-2031)
Table 68. Global Blocking Peptides Price (US$/Unit) by Application (2020-2025)
Table 69. Global Blocking Peptides Price (US$/Unit) by Application (2026-2031)
Table 70. amsbio Company Information
Table 71. amsbio Description and Business Overview
Table 72. amsbio Blocking Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. amsbio Blocking Peptides Product
Table 74. amsbio Recent Developments/Updates
Table 75. Abcam Company Information
Table 76. Abcam Description and Business Overview
Table 77. Abcam Blocking Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Abcam Blocking Peptides Product
Table 79. Abcam Recent Developments/Updates
Table 80. Fitzgerald Industries International Company Information
Table 81. Fitzgerald Industries International Description and Business Overview
Table 82. Fitzgerald Industries International Blocking Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Fitzgerald Industries International Blocking Peptides Product
Table 84. Fitzgerald Industries International Recent Developments/Updates
Table 85. Aviva Systems Biology Company Information
Table 86. Aviva Systems Biology Description and Business Overview
Table 87. Aviva Systems Biology Blocking Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Aviva Systems Biology Blocking Peptides Product
Table 89. Aviva Systems Biology Recent Developments/Updates
Table 90. Alomone Labs Company Information
Table 91. Alomone Labs Description and Business Overview
Table 92. Alomone Labs Blocking Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Alomone Labs Blocking Peptides Product
Table 94. Alomone Labs Recent Developments/Updates
Table 95. Merck Company Information
Table 96. Merck Description and Business Overview
Table 97. Merck Blocking Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Merck Blocking Peptides Product
Table 99. Merck Recent Developments/Updates
Table 100. Abcepta Company Information
Table 101. Abcepta Description and Business Overview
Table 102. Abcepta Blocking Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Abcepta Blocking Peptides Product
Table 104. Abcepta Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Blocking Peptides Distributors List
Table 108. Blocking Peptides Customers List
Table 109. Blocking Peptides Market Trends
Table 110. Blocking Peptides Market Drivers
Table 111. Blocking Peptides Market Challenges
Table 112. Blocking Peptides Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Blocking Peptides
Figure 2. Global Blocking Peptides Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Blocking Peptides Market Share by Type: 2024 & 2031
Figure 4. SSX2 Blocking Peptide Product Picture
Figure 5. KLK2 Blocking Peptide Product Picture
Figure 6. FZD4 Blocking Peptide Product Picture
Figure 7. SPDEF Blocking Peptide Product Picture
Figure 8. Others Product Picture
Figure 9. Global Blocking Peptides Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Blocking Peptides Market Share by Application: 2024 & 2031
Figure 11. Immunity Therapy
Figure 12. Chemical Analysis
Figure 13. Others
Figure 14. Global Blocking Peptides Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Blocking Peptides Market Size (2020-2031) & (US$ Million)
Figure 16. Global Blocking Peptides Sales (2020-2031) & (K Units)
Figure 17. Global Blocking Peptides Average Price (US$/Unit) & (2020-2031)
Figure 18. Blocking Peptides Report Years Considered
Figure 19. Blocking Peptides Sales Share by Manufacturers in 2024
Figure 20. Global Blocking Peptides Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Blocking Peptides Players: Market Share by Revenue in Blocking Peptides in 2024
Figure 22. Blocking Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Blocking Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Blocking Peptides Sales Market Share by Country (2020-2031)
Figure 25. North America Blocking Peptides Revenue Market Share by Country (2020-2031)
Figure 26. United States Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Blocking Peptides Sales Market Share by Country (2020-2031)
Figure 29. Europe Blocking Peptides Revenue Market Share by Country (2020-2031)
Figure 30. Germany Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Blocking Peptides Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Blocking Peptides Revenue Market Share by Region (2020-2031)
Figure 37. China Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Blocking Peptides Sales Market Share by Country (2020-2031)
Figure 47. Latin America Blocking Peptides Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Blocking Peptides Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Blocking Peptides Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Blocking Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Blocking Peptides by Type (2020-2031)
Figure 57. Global Revenue Market Share of Blocking Peptides by Type (2020-2031)
Figure 58. Global Blocking Peptides Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Blocking Peptides by Application (2020-2031)
Figure 60. Global Revenue Market Share of Blocking Peptides by Application (2020-2031)
Figure 61. Global Blocking Peptides Price (US$/Unit) by Application (2020-2031)
Figure 62. Blocking Peptides Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
